CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
about
Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing OncologistExtensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples.Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathologyCD24+/CD38- as new prognostic marker for non-small cell lung cancer.Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes.The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemiaA molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients.CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia.Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia.Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemiaCD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.The clinical and epidemiological burden of chronic lymphocytic leukaemia.Characteristics of chronic lymphocytic leukemia in SenegalCD38 as a prognostic marker in CLL.CD38 and chronic lymphocytic leukemia: a decade later.A reliable Raman-spectroscopy-based approach for diagnosis, classification and follow-up of B-cell acute lymphoblastic leukemiaRelative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaGenomic complexity identifies patients with aggressive chronic lymphocytic leukemiaA high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.Quantitative detection of zeta-chain-associated protein 70 expression in chronic lymphocytic leukemiaSurface profiles for subclassification of chronic lymphocytic leukemia.Prognostic Factors for Chronic Lymphocytic Leukemia.Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.Differential diagnosis problems in a patient with dysphonia and chronic lymphocytic leukemiaGenetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.Role of CD21 antigen in diffuse large B-cell lymphoma and its clinical significance.miR-708-5p: a microRNA with emerging roles in cancer.ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.Serum copper is a simple but valuable prognostic marker in B-cell chronic lymphocytic leukemia.Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient.Unexpectedly high frequency of European parentage in Venezuelan patients with chronic lymphocytic leukemia.B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors.Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.Evaluation of Interleukin-9 Expression as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia in a Cohort of Egyptian Patients.CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma.
P2860
Q26775986-F86E3EAB-43F8-4B77-817F-9A346F34596EQ27303212-D603CC57-383B-4C0B-82AF-F78F99438999Q28287124-8568C8F7-144F-49B9-9AD5-819D03EF2699Q30446381-997ABC12-A75C-4581-A842-8CB51E5C2BD8Q31011471-AD370F49-103C-4787-A761-91A6E22F158DQ33655756-7478B767-2E32-46A1-9221-CE4F5B19E80AQ33700437-8D0DC5F2-DE56-41EB-A416-32B2B701196EQ33829089-F4D9EA70-7643-42A9-9472-969AE6C79D52Q34016413-129C6693-AA75-43CF-8D9A-56EDD1FDE4E3Q34217900-D61CF40A-E58B-4F70-954E-FBEE7C238CA2Q34925487-14FC4A99-DD99-4CA1-B606-BF5886651F38Q35104372-D803B8C2-B3C5-489B-8EE9-5D6F174E347AQ35118658-FB4AF555-344C-4B95-93F7-21D49834975DQ35405550-B9AAEDD0-24C0-4C7A-834C-27E38019A36BQ35804467-384722A3-70A9-448C-BEA0-19072E94F487Q35997917-F4EE5517-89BB-487E-A02B-4ED78EACA595Q36194534-40794846-5F20-4A51-96BD-19563CB178B4Q36615126-BB7FF101-B1DD-4382-A26F-8D5798F0B618Q36810101-702F243E-E5FA-42FE-AC1C-9B447AAFF11BQ36843749-F62B4E51-9FA5-47E0-BF0E-34558DB651D5Q36843780-445903A3-E56F-4BBA-920D-C3A20D6DC2DCQ37112857-B615823D-6266-46AA-A8C2-1F49C4EA615CQ37390202-81108B94-35B0-403B-9B53-59B9FA643EC2Q37948956-A2ED9B81-06DD-4D46-80CD-D441E0446CC0Q38691341-1536A3A3-12C7-48AB-A40F-312F9F61E6B8Q38721759-9DE10A16-C2C4-4A6D-ADA0-AB70C7573018Q39260356-90585D0C-2F2C-4532-9490-7740D84FF3F3Q39434928-5A6F2105-9699-4003-8927-0638934ED650Q40496898-D35E7B48-4D2C-4494-83D1-EE2E112A36A7Q42378530-14382B84-2E62-4367-8CEB-E68B848DDC07Q44605532-B3BE4421-BC68-464D-82A9-B2E9D229E5A5Q44635362-FB398D3D-018A-42A0-8DA8-88046204709FQ44636663-E1A2AE35-F56D-43B2-AFB5-922EE4421BE6Q44683894-717C7689-EBB4-45F3-862A-CC7B53FCAB95Q45061073-F37B0536-1ACD-4E8A-90E7-39D07E41DA10Q45073116-84092788-9FAA-4877-9B96-F0597D5CEBD9Q45916401-512F76CA-55FD-4F3A-B908-843C0C18C7CAQ46425559-507A5CC9-EC84-49D6-8F36-28E9E1AB15A2Q47307445-651C9F51-3EAD-4CF1-99F5-DF4A35217594Q47393395-A3DED0CC-FF37-4408-B376-D44BD065B1DA
P2860
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@ast
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@en
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@nl
type
label
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@ast
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@en
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@nl
prefLabel
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@ast
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@en
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
@nl
P2093
P356
P1433
P1476
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
@en
P2093
Renzing-Köhler K
Schmücker U
P2888
P356
10.1038/SJ.LEU.2402339
P577
2002-01-01T00:00:00Z
P5875
P6179
1011700153